Erratum: The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: A phase-III intergroup study (Annals of Hematology (1992) 65 (162-168))

K. Miller, M J O'Connell(Mayo Clinic in Arizona), John M. Bennett(University of Rochester Medical Center), David R. Head(University of Southern California), Richard S. Neiman(University Medical Center), Peter A. Cassileth(City Of Hope National Medical Center), Jane N. Winter(Northwestern University), Francis S. Morrison(Jackson Memorial Hospital), K. Kyungmann(Dana-Farber Cancer Institute)
Unknown
January 1, 1993
Cited by 2

Related Papers

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
Age and acute myeloid leukemia
|Blood|2006|1.4k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases
|Cancer|1981|974